Houte Hans Van - Net Worth and Insider Trading

Houte Hans Van Net Worth

The estimated net worth of Houte Hans Van is at least $1 Million dollars as of 2026-08-13. Houte Hans Van is the CFO of Nurix Therapeutics Inc and owns about 40,166 shares of Nurix Therapeutics Inc (NRIX) stock worth over $1 Million. Details can be seen in Houte Hans Van's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Houte Hans Van has not made any transactions after 2026-08-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Houte Hans Van

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Houte Hans Van Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Houte Hans Van owns 1 companies in total, including Nurix Therapeutics Inc (NRIX) .

Click here to see the complete history of Houte Hans Van’s form 4 insider trades.

Insider Ownership Summary of Houte Hans Van

Ticker Company Transaction Date Type of Owner
NRIX Nurix Therapeutics Inc 2026-08-04 Chief Financial Officer

Houte Hans Van Latest Holdings Summary

Houte Hans Van currently owns a total of 1 stock. Houte Hans Van owns 40,166 shares of Nurix Therapeutics Inc (NRIX) as of August 4, 2026, with a value of $1 Million.

Latest Holdings of Houte Hans Van

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NRIX Nurix Therapeutics Inc 2026-08-04 40,166 26.62 1,069,219

Holding Weightings of Houte Hans Van


Houte Hans Van Form 4 Trading Tracker

According to the SEC Form 4 filings, Houte Hans Van has made a total of 32 transactions in Nurix Therapeutics Inc (NRIX) over the past 5 years, including 0 buys and 32 sells. The most-recent trade in Nurix Therapeutics Inc is the sale of 4,761 shares on August 4, 2026, which brought Houte Hans Van around $115,978.

Insider Trading History of Houte Hans Van

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Houte Hans Van Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Houte Hans Van owns.
View NRIX Analysis

Houte Hans Van Ownership Network

Ownership Network List of Houte Hans Van

No Data

Ownership Network Relation of Houte Hans Van

Insider Network Chart


Houte Hans Van Owned Company Details

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

Houte Hans Van is the Chief Financial Officer of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include Chief Scientific Officer Gwenn Hansen , General Counsel Christine Ring , and EVP and COO Stefani Wolff .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, Houte Hans Van made 12 insider transaction in Nurix Therapeutics Inc (NRIX) with a net sale of 61,291. Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 175,760 shares made by Christine Ring , a net sale of 37,589 shares made by Gwenn Hansen ,

In summary, during the past 3 months, insiders sold 93,841 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 93,841 shares. During the past 18 months, 274,640 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 274,640 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nurix Therapeutics Inc Insider Transactions

No Available Data

Houte Hans Van Mailing Address

Above is the net worth, insider trading, and ownership report for Houte Hans Van. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Houte Hans Van's mailing address is: San Francisco Ca 94158.